Advanced search

A review of the safety of micafungin compared with liposomal amphotericin B in a large, phase III trial in patients with invasive candidiasis and candidaemia

Author

Citation

Please use this url to cite or link to this publication:

Chicago
ULLMANN, AJ, Jan De Waele, R BETTS, C ROTSTEIN, M NUCCI, and OA CORNELY. 2007. “A Review of the Safety of Micafungin Compared with Liposomal Amphotericin B in a Large, Phase III Trial in Patients with Invasive Candidiasis and Candidaemia.” In International Journal of Antimicrobial Agents, 29:257.
APA
ULLMANN, A., De Waele, J., BETTS, R., ROTSTEIN, C., NUCCI, M., & CORNELY, O. (2007). A review of the safety of micafungin compared with liposomal amphotericin B in a large, phase III trial in patients with invasive candidiasis and candidaemia. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (Vol. 29, p. 257).
Vancouver
1.
ULLMANN A, De Waele J, BETTS R, ROTSTEIN C, NUCCI M, CORNELY O. A review of the safety of micafungin compared with liposomal amphotericin B in a large, phase III trial in patients with invasive candidiasis and candidaemia. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2007. p. 257.
MLA
ULLMANN, AJ, Jan De Waele, R BETTS, et al. “A Review of the Safety of Micafungin Compared with Liposomal Amphotericin B in a Large, Phase III Trial in Patients with Invasive Candidiasis and Candidaemia.” International Journal of Antimicrobial Agents. Vol. 29. 2007. 257. Print.
@inproceedings{417908,
  author       = {ULLMANN, AJ and De Waele, Jan and BETTS, R and ROTSTEIN, C and NUCCI, M and CORNELY, OA},
  booktitle    = {INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS},
  issn         = {0924-8579},
  language     = {eng},
  pages        = {S257-S257},
  title        = {A review of the safety of micafungin compared with liposomal amphotericin B in a large, phase III trial in patients with invasive candidiasis and candidaemia},
  volume       = {29},
  year         = {2007},
}

Web of Science
Times cited: